Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 955.01 | 1440 / 1445 | 100% | 12.49 | 183 / 183 |
stomach | 99% | 656.13 | 354 / 359 | 99% | 8.70 | 283 / 286 |
intestine | 100% | 1061.58 | 966 / 966 | 98% | 7.49 | 514 / 527 |
lung | 100% | 1368.11 | 577 / 578 | 98% | 9.01 | 1128 / 1155 |
breast | 100% | 1149.11 | 459 / 459 | 96% | 9.29 | 1075 / 1118 |
skin | 100% | 1277.34 | 1808 / 1809 | 95% | 9.13 | 448 / 472 |
ovary | 100% | 1065.91 | 180 / 180 | 92% | 6.83 | 394 / 430 |
bladder | 100% | 1217.57 | 21 / 21 | 90% | 6.28 | 453 / 504 |
uterus | 100% | 1174.50 | 170 / 170 | 89% | 5.95 | 410 / 459 |
prostate | 100% | 895.07 | 245 / 245 | 89% | 6.14 | 448 / 502 |
kidney | 100% | 750.93 | 89 / 89 | 88% | 7.02 | 790 / 901 |
thymus | 100% | 1202.82 | 653 / 653 | 86% | 7.74 | 518 / 605 |
pancreas | 87% | 362.60 | 285 / 328 | 92% | 5.14 | 164 / 178 |
brain | 85% | 391.40 | 2244 / 2642 | 93% | 5.02 | 655 / 705 |
liver | 98% | 570.20 | 221 / 226 | 71% | 3.48 | 288 / 406 |
adrenal gland | 98% | 833.50 | 253 / 258 | 66% | 2.53 | 151 / 230 |
adipose | 100% | 1296.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1270.26 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2455.70 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1213.06 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1353.18 | 902 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 8.85 | 42 / 45 |
heart | 92% | 601.37 | 788 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 7.91 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 81% | 3.09 | 65 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006954 | Biological process | inflammatory response |
GO_1905653 | Biological process | positive regulation of artery morphogenesis |
GO_0010613 | Biological process | positive regulation of cardiac muscle hypertrophy |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_1902894 | Biological process | negative regulation of miRNA transcription |
GO_0001816 | Biological process | cytokine production |
GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1905064 | Biological process | negative regulation of vascular associated smooth muscle cell differentiation |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0006606 | Biological process | protein import into nucleus |
GO_0045059 | Biological process | positive thymic T cell selection |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_1904157 | Biological process | DN4 thymocyte differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NFATC3 |
Protein name | Nuclear factor of activated T-cells c3 isoform IAL-deltaXa (Nuclear factor of activated T-cells c3 isoform IAS-deltaXa) (Nuclear factor of activated T-cells c3 isoform IC-deltaXa) (Nuclear factor of activated T-cells c3 isoform ID-deltaXa) (Nuclear factor of activated T-cells c3 isoform IE-deltaXa) (Nuclear factor of activated T-cells c3 isoform IF-deltaXa) Nuclear factor of activated T-cells c3 isoform IAL-IX (Nuclear factor of activated T-cells c3 isoform IAS-IX) (Nuclear factor of activated T-cells c3 isoform IC-IX) (Nuclear factor of activated T-cells c3 isoform ID-IX) (Nuclear factor of activated T-cells c3 isoform IE-IX) (Nuclear factor of activated T-cells c3 isoform IF-IX) Nuclear factor of activated T-cells, cytoplasmic 3 (NF-ATc3) (NFATc3) (NFATx) (T-cell transcription factor NFAT4) (NF-AT4) (NF-AT4c) Nuclear factor of activated T-cells c3 isoform IB-deltaXa (Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3, isoform CRA_b) Nuclear factor of activated T-cells c3 isoform IB-Xa (Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3, isoform CRA_a) Nuclear factor of activated T-cells c3 isoform IAL-Xa (Nuclear factor of activated T-cells c3 isoform IAS-Xa) (Nuclear factor of activated T-cells c3 isoform IC-Xa) (Nuclear factor of activated T-cells c3 isoform ID-Xa) (Nuclear factor of activated T-cells c3 isoform IE-Xa) (Nuclear factor of activated T-cells c3 isoform IF-Xa) Nuclear factor of activated T cells 3 Nuclear factor of activated T-cells c3 isoform IB-IX |
Synonyms | NFAT4 hCG_28103 |
Description | FUNCTION: Acts as a regulator of transcriptional activation. Binds to the TNFSF11/RANKL promoter region and promotes TNFSF11 transcription (By similarity). Binding to the TNFSF11 promoter region is increased by high levels of Ca(2+) which induce NFATC3 expression and may lead to regulation of TNFSF11 expression in osteoblasts (By similarity). Plays a role in promoting mesenteric arterial wall remodeling in response to the intermittent hypoxia-induced increase in EDN1 and ROCK signaling (By similarity). As a result NFATC3 colocalizes with F-actin filaments, translocates to the nucleus and promotes transcription of the smooth muscle hypertrophy and differentiation marker ACTA2 (By similarity). Promotes lipopolysaccharide-induced apoptosis and hypertrophy in cardiomyocytes (By similarity). Following JAK/STAT signaling activation and as part of a complex with NFATC4 and STAT3, binds to the alpha-beta E4 promoter region of CRYAB and activates transcription in cardiomyocytes (By similarity). In conjunction with NFATC4, involved in embryonic heart development via maintenance of cardiomyocyte survival, proliferation and differentiation (By similarity). Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 . Required for thymocyte maturation during DN3 to DN4 transition and during positive selection (By similarity). Positively regulates macrophage-derived polymicrobial clearance, via binding to the promoter region and promoting transcription of NOS2 resulting in subsequent generation of nitric oxide (By similarity). . |
Accessions | H3BRM3 ENST00000565750.2 I3L3K7 B5B2S5 ENST00000562171.1 ENST00000568466.6 B5B2S0 ENST00000562926.5 H3BRS1 ENST00000349223.9 [Q12968-3] B5B2S3 H3BU30 ENST00000575270.5 ENST00000561714.5 Q12968 ENST00000329524.8 [Q12968-2] ENST00000570212.5 B5B2S1 H3BR83 B5B2S2 ENST00000539828.6 B5B2S4 F8VPH9 ENST00000346183.8 [Q12968-1] |